论文信息 - Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. - 字舞流文

Discussion on genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis.

P. Marteau | T. Bienvenu | X. Dray | D. Dusser | D. Hubert

[1] R. Chung,et al. Optimal IFN therapy for 40-year-old patients with severe HCV-1b infection. , 2003, Gastroenterology.

[2] M. Corey,et al. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. , 2002, Gastroenterology.

[3] Dieter Häussinger,et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. , 2002, The New England journal of medicine.

[4] R. Chung,et al. Management strategies using pharmacogenomics in patients with severe HCV‐1b infection: A decision analysis , 2002, Hepatology.

[5] M. Manns,et al. Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C. , 2002, Gastroenterology.

[6] S. Fulmer-Smentek,et al. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. , 1998, Human molecular genetics.

[7] M. Claustres,et al. Analysis of the 27 exons and flanking regions of the cystic fibrosis gene: 40 different mutations account for 91.2% of the mutant alleles in southern France. , 1993, Human molecular genetics.

[8] M. Welsh,et al. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis , 1993, Cell.